Identifying roles for GAPDH and Hsp90 in heme allocation to human CYP3A4 and 2D6 sheds new light on their cellular maturation processes and reveals new potential points of physiologic or pharmacologic control that could regulate their activities in drug metabolism, inflammation, cancer, or other diseases. This evidence concerns the gene GAPDH and cancer.